GlaxoSmithKline plc (GSK) Stock Price Up 2.1%
GlaxoSmithKline plc (LON:GSK) shot up 2.1% during trading on Monday . The company traded as high as GBX 1,525.50 ($20.23) and last traded at GBX 1,520.50 ($20.17). 6,298,473 shares were traded during mid-day trading, a decline of 8% from the average session volume of 6,814,230 shares. The stock had previously closed at GBX 1,488.50 ($19.74).
Several equities analysts have recently weighed in on the company. S&P Global set a GBX 1,500 ($19.90) price target on GlaxoSmithKline plc and gave the company a “sell” rating in a report on Tuesday, June 6th. Liberum Capital restated a “buy” rating and issued a GBX 1,900 ($25.20) price target on shares of GlaxoSmithKline plc in a research note on Tuesday, June 6th. Jefferies Group LLC lifted their price objective on GlaxoSmithKline plc from GBX 1,800 ($23.88) to GBX 1,900 ($25.20) and gave the stock a “buy” rating in a report on Friday, June 16th. UBS AG set a GBX 1,600 ($21.22) price objective on GlaxoSmithKline plc and gave the stock a “neutral” rating in a report on Friday, June 9th. Finally, Deutsche Bank AG reiterated a “hold” rating and set a GBX 1,720 ($22.81) price objective on shares of GlaxoSmithKline plc in a research report on Friday, June 30th. Four research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and seven have issued a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus target price of GBX 1,698.52 ($22.53).
The stock has a 50 day moving average of GBX 1,495.07 and a 200 day moving average of GBX 1,594.46. The stock’s market cap is GBX 74.32 billion.
The company also recently declared a dividend, which will be paid on Thursday, October 12th. Investors of record on Thursday, August 10th will be given a dividend of GBX 19 ($0.25) per share. This represents a dividend yield of 1.23%. The ex-dividend date is Thursday, August 10th.
In related news, insider Patrick Vallance bought 861 shares of the stock in a transaction dated Friday, July 14th. The stock was bought at an average cost of GBX 1,618 ($21.46) per share, with a total value of £13,930.98 ($18,478.55). Also, insider Manvinder Singh Banga purchased 2,267 shares of the company’s stock in a transaction dated Wednesday, July 26th. The shares were bought at an average price of GBX 1,599 ($21.21) per share, for a total transaction of £36,249.33 ($48,082.41). In the last ninety days, insiders acquired 3,152 shares of company stock valued at $5,055,023.
GlaxoSmithKline plc Company Profile
GlaxoSmithKline plc is a global healthcare company. The Company operates through three segments: Pharmaceuticals, Vaccines and Consumer Healthcare. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases.
Receive News & Ratings for GlaxoSmithKline plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GlaxoSmithKline plc and related companies with Analyst Ratings Network's FREE daily email newsletter.